HIGHLIGHTS
- who: Syed S. Islam from the (UNIVERSITY) have published the article: Sequential combination of cisplatin with eugenol targets ovarian cancer stem cells through the Notch-Hes1 signalling pathway, in the Journal: (JOURNAL)
- what: The present findings present the sequential combination of cisplatin and eugenol as an efficient inhibitor of the Notch signaling, and therefore could constitute a promising therapeutic option for ovarian cancer patients.
- how: For statistical analysis and graphing the authors used the R-statistical software (version 3.4.4). The combination was rather simultaneous while for OC cells the best results . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.